Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127689101 | 12768910 | 1 | I | 20160503 | 20160603 | 20160921 | 20160921 | PER | US-JAZZ-2016-US-010408 | JAZZ | 31.92 | YR | F | Y | 0.00000 | 20160921 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127689101 | 12768910 | 1 | PS | XYREM | SODIUM OXYBATE | 1 | Oral | 2.25 G, BID | 21196 | 2.25 | G | ORAL SOLUTION | |||||||
| 127689101 | 12768910 | 2 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3 G, BID | 21196 | 3 | G | ORAL SOLUTION | |||||||
| 127689101 | 12768910 | 3 | SS | XYREM | SODIUM OXYBATE | 1 | Oral | 3.75 G, BID | 21196 | 3.75 | G | ORAL SOLUTION | |||||||
| 127689101 | 12768910 | 4 | SS | ALLEGRA | FEXOFENADINE HYDROCHLORIDE | 1 | UNK | U | 0 | TABLET | |||||||||
| 127689101 | 12768910 | 5 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 127689101 | 12768910 | 6 | C | EXCEDRIN | ACETAMINOPHENASPIRINCAFFEINE | 1 | U | 0 | |||||||||||
| 127689101 | 12768910 | 7 | C | IBUPROFEN. | IBUPROFEN | 1 | U | 0 | |||||||||||
| 127689101 | 12768910 | 8 | C | Magnesium | MAGNESIUM | 1 | U | 0 | |||||||||||
| 127689101 | 12768910 | 9 | C | MAXALT | RIZATRIPTAN BENZOATE | 1 | U | 0 | |||||||||||
| 127689101 | 12768910 | 10 | C | Melatonin | MELATONIN | 1 | U | 0 | |||||||||||
| 127689101 | 12768910 | 11 | C | NUVARING | ETHINYL ESTRADIOLETONOGESTREL | 1 | U | 0 | |||||||||||
| 127689101 | 12768910 | 12 | C | Phentermine Hcl | PHENTERMINE HYDROCHLORIDE | 1 | U | 0 | |||||||||||
| 127689101 | 12768910 | 13 | C | TYLENOL EXTRA STRENGTH | ACETAMINOPHEN | 1 | U | 0 | |||||||||||
| 127689101 | 12768910 | 14 | C | VALTREX | VALACYCLOVIR HYDROCHLORIDE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127689101 | 12768910 | 1 | Narcolepsy |
| 127689101 | 12768910 | 4 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127689101 | 12768910 | Paraesthesia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127689101 | 12768910 | 1 | 201605 | 201605 | 0 | |
| 127689101 | 12768910 | 2 | 201605 | 201605 | 0 | |
| 127689101 | 12768910 | 3 | 201605 | 0 | ||
| 127689101 | 12768910 | 4 | 20160603 | 0 |